Table 2. Baseline laboratory data in propensity score-matched cohort.

Laboratory marker	No regdanvimab (n = 377)	Regdanvimab (n = 377)	P value	SMD
WBC, 103/µL	4.6 (3.7–5.9)	4.6 (3.7–5.9)	0.484	0.051
Hemoglobin, g/dL	13.5 (12.5–14.3)	13.5 (12.5–14.4)	0.444	0.056
Platelet count, 103/µL	187.0 (152.0–235.5)	180.0 (149.0–216.0)	0.005	0.205
Absolute neutrophil count, /µL	2,916 (2,154–3,926)	2,834 (2,037–3,982)	0.142	0.107
Absolute lymphocyte count, /µL	1,058 (790–1,431)	1,206 (928–1,564)	< 0.001	0.243
Na, mmol/L	139.0 (137.0–140.5)	139.0 (138.0–141.0)	0.002	0.224
K, mmol/L	4.0 (3.8–4.2)	4.0 (3.7–4.2)	0.306	0.075
Creatinine, mg/dL	0.7 (0.6–0.9)	0.7 (0.6–0.9)	0.703	0.028
GFR, mL/min	97.2 (79.9–110.8)	95.8 (80.0–110.6)	0.626	0.036
AST, IU/L	28.0 (22.0–38.0)	26.0 (21.0–32.0)	0.202	0.093
ALT, IU/L	23.0 (17.0–36.0)	23.0 (17.0–34.0)	0.488	0.051
Total bilirubin, mg/dL	0.5 (0.4–0.7)	0.6 (0.4–0.7)	0.847	0.014
CRP, mg/dL	0.7 (0.4–2.7)	0.4 (0.4–1.8)	< 0.001	0.255
LDH, IU/L	216.0 (190.5–257.0)	206.0 (180.8–240.0)	0.011	0.185
D-dimer, ng/mL	138.5 (95.8–224.5)	146.0 (102.8–208.0)	0.101	0.125
Troponin I, ng/mL	0.004 (0.002–0.009)	0.004 (0.003–0.006)	0.860	0.014
Ferritin, ng/mL	221.5 (124.3–378.3)	169.0 (100.5–307.0)	0.048	0.158
Creatine kinase, U/L	83.0 (58.0–123.2)	79.0 (55.3–116.0)	0.800	0.019

Data are presented as medians (interquartile range). Variables were analyzed using Student t-tests.

SMD = standardized mean difference, WBC = white blood cell, GFR = glomerular filtration rate, AST = aspartate transaminase, ALT = alanine transaminase, CRP = C-reactive protein, LDH = lactate dehydrogenase.